Wei Jian: speeding up the approval of the nine price cervical cancer vaccine and striving for an early listing

category:Society
 Wei Jian: speeding up the approval of the nine price cervical cancer vaccine and striving for an early listing


When it comes to how to reduce the burden of cancer patients, Ceng Yixin said he will establish a long-term mechanism to reduce the reasonable burden of cancer drugs. These include improving the ability to review, streamlining the examination and approval procedures and speeding up the listing of cancer control drugs. For example, the nine price cervical cancer vaccine, which is relatively concerned by the early media, is speeding up the progress of the work and striving for early approval of the listing. Zeng Yi Xin said. At the same time, we should increase the support of the national science and technology plan for the research and development of anticancer drugs, and establish a sustained and stable support mechanism for the research and development of domestic anticancer drugs. For the urgent need of anticancer drugs, we should give priority to R & D, encourage the research and original innovation of new anticancer targets, new mechanism drugs, encourage the imitating research on the urgent and imminent anti-cancer drugs which are due to expire, and improve the drug selectivity. The cost of drug circulation will also be reduced. Ceng Yixin said it would crack down on illegal acts such as commercial bribery and price monopoly. This year, the drug two vote system has been comprehensively pushed forward to increase the price of the circulation links more transparent, and to squeeze the price high and high. In addition, improve the diagnosis and treatment ability and rational use of anticancer drugs. We should adhere to the guidance of clinical value, strengthen the inspection and guidance for clinical use of drugs, formulate and improve the clinical path of cancer and accelerate the implementation of cancer, promote the standardized diagnosis and treatment of cancer, promote the clinical medication guide for cancer, carry out the prescription audit of pharmacists and guide the clinical medication, and improve the rational use of medicine. Source: Beijing News Editor: Qiao Jing _NN6607 At the same time, we should increase the support of the national science and technology plan for the research and development of anticancer drugs, and establish a sustained and stable support mechanism for the research and development of domestic anticancer drugs. For the urgent need of anticancer drugs, we should give priority to R & D, encourage the research and original innovation of new anticancer targets, new mechanism drugs, encourage the imitating research on the urgent and imminent anti-cancer drugs which are due to expire, and improve the drug selectivity. The cost of drug circulation will also be reduced. Ceng Yixin said it would crack down on illegal acts such as commercial bribery and price monopoly. This year, the drug two vote system has been comprehensively pushed forward to increase the price of the circulation links more transparent, and to squeeze the price high and high. In addition, improve the diagnosis and treatment ability and rational use of anticancer drugs. We should adhere to the guidance of clinical value, strengthen the inspection and guidance for clinical use of drugs, formulate and improve the clinical path of cancer and accelerate the implementation of cancer, promote the standardized diagnosis and treatment of cancer, promote the clinical medication guide for cancer, carry out the prescription audit of pharmacists and guide the clinical medication, and improve the rational use of medicine.